Skip to main content
. Author manuscript; available in PMC: 2011 Jul 6.
Published in final edited form as: J Addict Res Ther. 2011 May 13;2(2):2–10. doi: 10.4172/2155-6105.1000109

Table 2.

Treatment Group Differences on Primary Single Endpoint Outcomes.

Outcome CBT
(n=14)		 Standard
Care (N=15)		 Odds Ratio
(95% CI)		 Adjusted
Odds Ratio
(95% CI)
Depression-Related
Treatment Failure		 28.6%
(n=4)		 13.3% (n=2) 3.11 (0.47,
20.65)		 1.89 (0.24,
15.11)
Complete Treatment Ad-
herence (24 injections)		 50.0%
(n=7)		 80.0%
(n=12)		 0.25 (0.05,
1.29)		 0.19 (0.03,
1.15)
Hep C RNA Detectable
(24 weeks)		 20.0%
(n=2/10)		 20.0%
(n=3/15)		 1.24 (0.17,
9.25)		 NA
Hep C RNA Detectable
(48 weeks)		 20.0%
(n=2/10)		 42.9%
(n=6/14)		 0.43 (0.07,
2.81)		 NA

Note: NA=adjusted odds ratios were not calculated for these outcomes